{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:28:21Z","timestamp":1792686501618,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jtha.2024.11.024","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T17:26:28Z","timestamp":1733851588000},"page":"779-789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Safe and effective anticoagulation use: case studies in anticoagulation stewardship"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7744-5700","authenticated-orcid":false,"given":"Jori E.","family":"May","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur L.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany T.","family":"Samuelson Bannow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlee","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn W.","family":"Sylvester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Kaatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.11.024_bib1","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jama.2021.13844","article-title":"US emergency department visits attributed to medication harms, 2017-2019","volume":"326","author":"Budnitz","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2024.11.024_bib2","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1001\/jama.2016.16201","article-title":"US emergency department visits for outpatient adverse drug events, 2013-2014","volume":"316","author":"Shehab","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2024.11.024_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12757","article-title":"A\u00a0call to action for anticoagulation stewardship","volume":"6","author":"Burnett","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.024_bib4","series-title":"Core Elements of Anticoagulation Stewardship Programs","year":"2019"},{"key":"10.1016\/j.jtha.2024.11.024_bib5","series-title":"Advancing Anticoagulation Stewardship: A Playbook","year":"2022"},{"key":"10.1016\/j.jtha.2024.11.024_bib6","article-title":"Rates of potentially inappropriate dosing of direct-acting oral anticoagulants and associations with geriatric conditions among older patients with atrial fibrillation: the SAGE-AF study","volume":"9","author":"Sanghai","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jtha.2024.11.024_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11239-016-1435-3","article-title":"Identification of risk factors for inappropriate and suboptimal initiation of direct oral anticoagulants","volume":"43","author":"Howard","year":"2017","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.11.024_bib8","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/14779072.2021.2013816","article-title":"Off-label direct oral anticoagulants dosing in atrial fibrillation and venous thromboembolism is associated with higher mortality","volume":"19","author":"Aguilar","year":"2021","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.jtha.2024.11.024_bib9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/bcp.14127","article-title":"Impact of direct oral anticoagulant off-label doses on clinical outcomes of atrial fibrillation patients: a systematic review","volume":"86","author":"Santos","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jtha.2024.11.024_bib10","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jacc.2020.07.045","article-title":"Mortality in patients with atrial fibrillation receiving nonrecommended doses of direct oral anticoagulants","volume":"76","author":"Camm","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2024.11.024_bib11","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1160\/TH16-07-0494","article-title":"Real-life treatment of venous thromboembolism with direct oral anticoagulants: rhe influence of recommended dosing and regimens","volume":"117","author":"Trujillo-Santos","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.024_bib12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jamainternmed.2021.1197","article-title":"Adverse events associated with the addition of aspirin to direct oral anticoagulant therapy without a clear indication","volume":"181","author":"Schaefer","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jtha.2024.11.024_bib13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jamainternmed.2018.7816","article-title":"Association of adding aspirin to warfarin therapy without an apparent indication with bleeding and other adverse events","volume":"179","author":"Schaefer","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jtha.2024.11.024_bib14","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2024.11.024_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.11.024_bib16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.120.050438","article-title":"Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a North American perspective: 2021 update","volume":"143","author":"Angiolillo","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.11.024_bib17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1161\/CIRCOUTCOMES.115.002366","article-title":"Reimagining anticoagulation clinics in the era of direct oral anticoagulants","volume":"9","author":"Barnes","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jtha.2024.11.024_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12696","article-title":"Optimization of DOAC management services in a centralized anticoagulation clinic","volume":"6","author":"Sylvester","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.024_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12735","article-title":"Are outpatient anticoagulation management services the wave of the future (again)?","volume":"6","author":"Samuelson Bannow","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.024_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.31973","article-title":"Assessment of an intervention to reduce aspirin prescribing for patients receiving warfarin for anticoagulation","volume":"5","author":"Schaefer","year":"2022","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.jtha.2024.11.024_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13584-019-0285-9","article-title":"Clinical pharmacist led hospital-wide direct oral anticoagulant stewardship program","volume":"8","author":"Perlman","year":"2019","journal-title":"Isr J Health Policy Res"},{"key":"10.1016\/j.jtha.2024.11.024_bib22","article-title":"Shifting the paradigm: a population health approach to the management of direct oral anticoagulants","volume":"10","author":"Allen","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jtha.2024.11.024_bib23","article-title":"Pharmacist use of a population management dashboard for safe anticoagulant prescribing: evaluation of a nationwide implementation effort","volume":"13","author":"Barnes","year":"2024","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jtha.2024.11.024_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11239-023-02893-9","article-title":"Digital dashboards for direct oral anticoagulant surveillance, intervention and operational efficiency: uptake, obstacles, and opportunities","volume":"57","author":"Triller","year":"2024","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.11.024_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100283","article-title":"Heparin-induced thrombocytopenia: an illustrated review","volume":"7","author":"May","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.024_bib26","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.11.024_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102219","article-title":"Quality improvement approaches to heparin-induced thrombocytopenia: a scoping review","volume":"7","author":"Cogan","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.024_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102423","article-title":"Electronic alerts to improve management of heparin-induced thrombocytopenia","volume":"8","author":"Zon","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.024_bib29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11239-015-1189-3","article-title":"Implementation of a hemostatic and antithrombotic stewardship program","volume":"40","author":"Reardon","year":"2015","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.11.024_bib30","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s11239-016-1408-6","article-title":"Treatment of heparin-induced thrombocytopenia before and after the implementation of a hemostatic and antithrombotic stewardship program","volume":"42","author":"Ritchie","year":"2016","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.11.024_bib31","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1177\/08971900221116185","article-title":"The impact of an antithrombotic stewardship program on heparin-induced thrombocytopenia management","volume":"36","author":"Lee","year":"2023","journal-title":"J\u00a0Pharm Pract"},{"key":"10.1016\/j.jtha.2024.11.024_bib32","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11239-016-1381-0","article-title":"Heparin-induced thrombocytopenia: reducing misdiagnosis via collaboration between an inpatient anticoagulation pharmacy service and hospital reference laboratory","volume":"42","author":"Burnett","year":"2016","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.11.024_bib33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11239-017-1592-z","article-title":"Initial and long term impact of a multi-disciplinary task force in the diagnosis and management of heparin-induced thrombocytopenia","volume":"45","author":"Lim","year":"2018","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.11.024_bib34","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood-2015-07-660001","article-title":"Reducing the hospital burden of heparin-induced thrombocytopenia: impact of an avoid-heparin program","volume":"127","author":"McGowan","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.11.024_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102537","article-title":"Electronic consultation to improve care outcomes in patients with suspected and confirmed heparin-induced thrombocytopenia","volume":"8","author":"May","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.024_bib36","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","article-title":"Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Douketis","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.11.024_bib37","article-title":"Trends in oral anticoagulant use among 436 864 patients with atrial fibrillation in community practice, 2011 to 2020","volume":"11","author":"Navar","year":"2022","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jtha.2024.11.024_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gie.2015.09.035","article-title":"The management of antithrombotic agents for patients undergoing GI endoscopy","volume":"83","author":"ASGE Standards of Practice Committee","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jtha.2024.11.024_bib39","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1016\/j.chest.2022.07.025","article-title":"Perioperative management of antithrombotic therapy: an American College of Chest Physicians clinical practice guideline","volume":"162","author":"Douketis","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.11.024_bib40","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s11239-023-02794-x","article-title":"A\u00a0scoping review of direct oral anticoagulant ambulatory management practices","volume":"55","author":"Mangrum","year":"2023","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.11.024_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029879","article-title":"How reliable is perioperative anticoagulant management? Determining guideline compliance and practice variation by a retrospective patient record review","volume":"9","author":"Moesker","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jtha.2024.11.024_bib42","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1111\/jth.14903","article-title":"Periprocedural bridging anticoagulation in patients with venous thromboembolism: a registry-based cohort study","volume":"18","author":"Barnes","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.024_bib43","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s12871-023-02276-w","article-title":"Clinicians\u2019 adherence to guidelines for the preoperative management of direct oral anticoagulants in a tertiary hospital: a retrospective study","volume":"23","author":"Terrier","year":"2023","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.jtha.2024.11.024_bib44","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11239-023-02854-2","article-title":"Standardizing periprocedural anticoagulation management: a stewardship initiative","volume":"56","author":"Rudd","year":"2023","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.11.024_bib45","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1055\/a-2098-6782","article-title":"Potential for a virtual care model in the perioperative management of anticoagulant therapy: a 5-year retrospective clinic review","volume":"7","author":"Douketis","year":"2023","journal-title":"TH Open"},{"key":"10.1016\/j.jtha.2024.11.024_bib46","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620925910","article-title":"Implementation of the management of anticoagulation in the Periprocedural Period app into an electronic health record: a prospective cohort study","volume":"26","author":"Spyropoulos","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.11.024_bib47","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.thromres.2015.07.030","article-title":"Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonists","volume":"136","author":"De Crem","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.11.024_bib48","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.thromres.2020.11.014","article-title":"Heavy menstrual bleeding in women on oral anticoagulants","volume":"197","author":"Samuelson Bannow","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.11.024_bib49","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12325-020-01564-y","article-title":"A\u00a0review of clinical guidelines on the management of iron deficiency and iron-deficiency anemia in women with heavy menstrual bleeding","volume":"38","author":"Mansour","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.jtha.2024.11.024_bib50","doi-asserted-by":"crossref","first-page":"364","DOI":"10.5468\/ogs.22308","article-title":"Endometrial ablation and resection versus hysterectomy for heavy menstrual bleeding: an updated systematic review and meta-analysis of effectiveness and complications","volume":"66","author":"Deehan","year":"2023","journal-title":"Obstet Gynecol Sci"},{"key":"10.1016\/j.jtha.2024.11.024_bib51","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.jtha.2024.04.002","article-title":"Management of abnormal uterine bleeding on anticoagulation: the patient-clinician perspective","volume":"22","author":"Samuelson Bannow","year":"2024","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.024_bib52","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.vph.2016.11.003","article-title":"Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolism","volume":"87","author":"Bryk","year":"2016","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jtha.2024.11.024_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.05.001","article-title":"Abnormal uterine bleeding in women receiving direct oral anticoagulants for the treatment of venous thromboembolism","volume":"93\u201395","author":"Godin","year":"2017","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jtha.2024.11.024_bib54","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/jth.14226","article-title":"Less abnormal uterine bleeding with dabigatran than warfarin in women treated for acute venous thromboembolism","volume":"16","author":"Huisman","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.024_bib55","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","article-title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","volume":"127","author":"Martinelli","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.11.024_bib56","series-title":"Heavy menstrual bleeding: assessment and management. National Institute for Health and Care Excellence: Clinical Guidelines","year":"2021"},{"key":"10.1016\/j.jtha.2024.11.024_bib57","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1542\/peds.2006-2481","article-title":"Menstruation in girls and adolescents: using the menstrual cycle as a vital sign","volume":"118","author":"Diaz","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jtha.2024.11.024_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102448","article-title":"Heavy menstrual bleeding on direct factor Xa inhibitors: the MEDEA randomized clinical trial","volume":"8","author":"Hamuly\u00e1k","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.11.024_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.tru.2023.100158","article-title":"Value of hospital anticoagulation stewardship programme: a systematic review","volume":"14","author":"Silvari","year":"2024","journal-title":"Thromb Update"},{"key":"10.1016\/j.jtha.2024.11.024_bib60","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1345\/aph.18192","article-title":"Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service","volume":"34","author":"Dager","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jtha.2024.11.024_bib61","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11239-017-1602-1","article-title":"Expanding anticoagulation management services to include direct oral anticoagulants","volume":"45","author":"Sylvester","year":"2018","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.11.024_bib62","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2146\/ajhp151026","article-title":"Evaluation of a pharmacist-led outpatient direct oral anticoagulant service","volume":"74","author":"Ashjian","year":"2017","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jtha.2024.11.024_bib63","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1177\/08971900231166555","article-title":"The impact of clinical pharmacy services on direct oral anticoagulant medication selection and dosing in the ambulatory care setting","volume":"37","author":"Yates","year":"2024","journal-title":"J\u00a0Pharm Pract"},{"key":"10.1016\/j.jtha.2024.11.024_bib64","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.122.009256","article-title":"Nationwide implementation of a population management dashboard for monitoring direct oral anticoagulants: insights from the Veterans Affairs health system","volume":"16","author":"Dorsch","year":"2023","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jtha.2024.11.024_bib65","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s11239-023-02880-0","article-title":"Digital dashboards for oral anticoagulation management: a literature scoping review","volume":"56","author":"Wilson","year":"2023","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.11.024_bib66","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/jac5.1614","article-title":"Hemostatic and antithrombotic stewardship programs: A toolkit for program implementation","volume":"5","author":"Dane","year":"2022","journal-title":"J\u00a0Am Coll Clin Pharm"},{"key":"10.1016\/j.jtha.2024.11.024_bib67","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1076029617693941","article-title":"Identification of cost-saving opportunities for the use of antithrombin III in adult and pediatric patients","volume":"24","author":"Ciolek","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.11.024_bib68","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s11239-016-1455-z","article-title":"The scope and value of an anticoagulation stewardship program at a community teaching hospital","volume":"43","author":"Wychowski","year":"2017","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.11.024_bib69","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11239-023-02886-8","article-title":"Pharmacist driven anticoagulation reversal program at a large academic medical center","volume":"57","author":"Procopio","year":"2024","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.11.024_bib70","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11239-021-02491-7","article-title":"Impact of a pharmacist driven anticoagulation reversal program at a large academic medical center","volume":"53","author":"Procopio","year":"2022","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.11.024_bib71","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/0897190013514091","article-title":"Development of an anticoagulation stewardship program at a large tertiary care academic institution","volume":"28","author":"Padron","year":"2015","journal-title":"J\u00a0Pharm Pract"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624007141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624007141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T14:58:05Z","timestamp":1741273085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624007141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1538783624007141"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.11.024","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safe and effective anticoagulation use: case studies in anticoagulation stewardship","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}